DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 0.00 0.00%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

67.57 0.40 (0.60%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $67.57 0.60%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $66.84
Previous Close $67.17
Daily Range $66.50 - $68.09
52-Week Range $25.82 - $77.80
Market Cap $8.1B
P/E Ratio -338.80
Dividend (Yield) $0.00 (0.0%)
Volume 1,284,341
Average Daily Volume 2,317,430
Current FY EPS -$0.37

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

IWM, VGLT: Big ETF Inflows

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Just What Is Invested Capital Anyway?

IWM, QRVO, ISIS, JBLU: ETF Inflow Alert

4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Akers Biosciences (AKER) Q1 Earnings: What's in Store? - Analyst Blog

Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development

Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio

See More ISIS News...

ISIS's Top Competitors

ISIS $67.57 (0.60%)
Current stock: ISIS
AMGN $163.58 (-0.16%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB